Related Experiment Video
Updated: Dec 15, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.6K
Lasmiditan Is a New Option for Acute Migraine Treatment
Nursing for Women'S Health
|July 15, 2020
Summary
Lasmiditan (Reyvow) is a novel oral medication for acute migraine treatment, representing a new class of drugs called ditans. It offers an alternative for patients unresponsive or contraindicated to other migraine therapies.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a prevalent neurological disorder impacting millions globally.
- Existing acute treatments like triptans have limitations for some patients.
Purpose of the Study:
- To introduce Lasmiditan, a novel oral medication for acute migraine.
- To highlight its potential as a new therapeutic option in the ditan drug class.
Main Methods:
- Review of clinical studies and FDA approval data for Lasmiditan.
- Analysis of Lasmiditan's mechanism of action and therapeutic applications.
Main Results:
- Lasmiditan, marketed as Reyvow, received FDA approval in October 2019.
- It is the first drug in the ditan class, offering a new treatment modality.
Conclusions:
- Lasmiditan provides a new oral treatment option for acute migraine.
- It may benefit patients who have not responded to or cannot use other acute migraine treatments.
Related Concept Videos
01:19Management of Insomnia
430
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
430
01:17Drugs for Treatment of Diarrhea-Predominant IBS
506
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
506
01:21Drugs for Treatment of Constipation-Predominant IBS
569
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
569
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
1.1K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.1K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
384
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
384
01:30Local Anesthetics: Chemistry and Structure-Activity Relationship
6.2K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.2K